SCHEMBL4489928

SCHEMBL4489928

CCCCCCCCCCCOCC(C)C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.57
HTT P42858 2/20 0.55
SPHK1 Q9NYA1 1/20 0.55
PRKD3 O94806 1/20 0.48
PRKCG P05129 1/20 0.48
PRKCB P05771 1/20 0.48
PRKCA P17252 1/20 0.48
PRKCH P24723 1/20 0.48
PRKCI P41743 1/20 0.48
PRKCE Q02156 1/20 0.48
PRKCQ Q04759 1/20 0.48
PRKCZ Q05513 1/20 0.48
PRKCD Q05655 1/20 0.48
PRKD1 Q15139 1/20 0.48
MEN1 O00255 1/20 0.48
THRB P10828 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPT P10636 1/20 0.48
LPAR1 Q92633 7/20 0.47
LPAR3 Q9UBY5 7/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4493893 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG
SCHEMBL6808833 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG
SCHEMBL10151451 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG
SCHEMBL10151453 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG
SCHEMBL4483278 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG
SCHEMBL10151450 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG
SCHEMBL10151448 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG
SCHEMBL3794737 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG
SCHEMBL2766746 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG
SCHEMBL12958570 1.00 USP2 (0.57) USP2HTTSPHK1PRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10022455-B2 Biodegradable lipids for delivery of nucleic acids TRANSLATE BIO, INC. (US) 2018-07-17 US disclosed
US-20180036333-A9 AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-02-08 US disclosed
US-9872911-B2 Alpha-aminoamidine polymers and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-01-23 US disclosed
US-20170281542-A1 LIPID FORMULATIONS FOR DELIVERY OF MESSENGER RNA MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2017-10-05 US disclosed
US-20170246319-A1 BIODEGRADABLE LIPIDS FOR DELIVERY OF NUCLEIC ACIDS SHIRE HUMAN GENETIC THERAPIES, INC. 2017-08-31 US disclosed
US-20170204075-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-07-20 US disclosed
US-20170165290-A1 AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-06-15 US disclosed
US-9629804-B2 Lipid formulations for delivery of messenger RNA SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2017-04-25 US disclosed
US-9556110-B2 Aminoalcohol lipidoids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-01-31 US disclosed
US-9512073-B2 Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-12-06 US disclosed
WO-2012135025-A2 CONJUGATED LIPOMERS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-10-04 WO disclosed
WO-2012027675-A2 POLY(BETA-AMINO ALCOHOLS), THEIR PREPARATION, AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-03-01 WO disclosed
US-20110293703-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-12-01 US disclosed
US-20100331234-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-12-30 US disclosed
US-20100331234-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-12-30 US disclosed
WO-2010053572-A2 AMINOALCOHOL LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-05-14 WO disclosed
US-20090318513-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN RECEPTOR AGONISM SHIONOGI & CO., LTD. 2009-12-24 US disclosed
US-7601746-B2 Compounds exhibiting thrombopoietin receptor agonism SHIONOGI & CO., LTD. (JP) 2009-10-13 US disclosed
US-20070043087-A1 Such as 3-{2,6-difluoro-4-[4,5-dihydro-6-(3,3-dimethylbutyl)naphtho[1,2-d]thiazol-2-ylcabamoyl)phenyl]-2-methylacrylic acid EDDINGPHARM (HONG KONG) COMPANY LIMITED (CN) 2007-02-22 US disclosed
EP-1655291-A1 COMPOUNDS HAVING THROMBOPOIETIN RECEPTOR AGONISM SHIONOGI & CO., LTD. (JP) 2006-05-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10022455-B2 Biodegradable lipids for delivery of nucleic acids LIPA, SLC67A1, SREBF1 USP2 3787/4885HTT 2039/4885SPHK1 137/4885
US-20170246319-A1 BIODEGRADABLE LIPIDS FOR DELIVERY OF NUCLEIC ACIDS LIPA, SLC67A1, SREBF1 USP2 3787/4885HTT 2039/4885SPHK1 137/4885
US-20090318513-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN RECEPTOR AGONISM MPL, TEK, GHRHR USP2 3710/4885HTT 1255/4885SPHK1 759/4885
US-20170281542-A1 LIPID FORMULATIONS FOR DELIVERY OF MESSENGER RNA RNMT, NSUN3, IGF2BP3 USP2 3317/4885HTT 2595/4885SPHK1 317/4885
US-20110293703-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF PHOSPHO1, PNMT, AASDHPPT USP2 3323/4885HTT 4362/4885SPHK1 913/4885
US-20070043087-A1 Such as 3-{2,6-difluoro-4-[4,5-dihydro-6-(3,3-dimethylbutyl)naphtho[1,2-d]thiazol-2-ylcabamoyl)phenyl]-2-methylacrylic acid DHFR, NAT1, ACR USP2 3145/4885HTT 1183/4885SPHK1 2792/4885
US-20170204075-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF PHOSPHO1, PNMT, AASDHPPT USP2 3323/4885HTT 4362/4885SPHK1 913/4885
US-20170165290-A1 AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF APLNR, NPPA, ARGLU1 USP2 4646/4885HTT 2610/4885SPHK1 2133/4885
US-20180036333-A9 AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF APLNR, NPPA, ARGLU1 USP2 4646/4885HTT 2610/4885SPHK1 2133/4885
US-20100331234-A1 AMINOALCOHOL LIPIDOIDS AND USES THEREOF PHOSPHO1, PNMT, AASDHPPT USP2 3323/4885HTT 4362/4885SPHK1 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.